Literature DB >> 24503069

The roles of hemagglutinin Phe-95 in receptor binding and pathogenicity of influenza B virus.

Fengyun Ni1, Innocent Nnadi Mbawuike2, Elena Kondrashkina3, Qinghua Wang4.   

Abstract

Diverged ~4000 years ago, influenza B virus has several important differences from influenza A virus, including lower receptor-binding affinity and highly restricted host range. Based on our prior structural studies, we hypothesized that a single-residue difference in the receptor-binding site of hemagglutinin (HA), Phe-95 in influenza B virus versus Tyr-98 in influenza A/H1-H15, is possibly a key determinant for the low receptor-binding affinity. Here we demonstrate that the mutation Phe95Tyr in influenza B virus HA restores all three hydrogen bonds made by Tyr-98 in influenza A/H1-15 HA and has the potential to enhance receptor binding. However, the full realization of this potential is influenced by the local environment into which the mutation is introduced. The binding and replication of the recombinant viruses correlate well with the receptor-binding capabilities of HA. These results are discussed in relation to the roles of Phe-95 in receptor binding and pathogenicity of influenza B virus.
© 2013 Published by Elsevier Inc.

Entities:  

Keywords:  Hemagglutinin; Host range; Influenza virus; Pathogenicity; Receptor-binding affinity

Mesh:

Substances:

Year:  2013        PMID: 24503069      PMCID: PMC4002292          DOI: 10.1016/j.virol.2013.11.038

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  64 in total

1.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

2.  Reappearance of influenza B/Victoria/2/87-lineage viruses: epidemic activity, genetic diversity and vaccination efficacy in the Finnish Defence Forces.

Authors:  N Ikonen; R Pyhälä; T Axelin; M Kleemola; H Korpela
Journal:  Epidemiol Infect       Date:  2005-04       Impact factor: 2.451

3.  Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities.

Authors:  James Stevens; Ola Blixt; Laurel Glaser; Jeffery K Taubenberger; Peter Palese; James C Paulson; Ian A Wilson
Journal:  J Mol Biol       Date:  2005-11-18       Impact factor: 5.469

4.  Selection of receptor-binding variants of human influenza A and B viruses in baby hamster kidney cells.

Authors:  E A Govorkova; M N Matrosovich; A B Tuzikov; N V Bovin; C Gerdil; B Fanget; R G Webster
Journal:  Virology       Date:  1999-09-15       Impact factor: 3.616

5.  Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls.

Authors:  Ron A M Fouchier; Vincent Munster; Anders Wallensten; Theo M Bestebroer; Sander Herfst; Derek Smith; Guus F Rimmelzwaan; Björn Olsen; Albert D M E Osterhaus
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

6.  Exploration of the emergence of the Victoria lineage of influenza B virus.

Authors:  J-M Chen; Y-J Guo; K-Y Wu; J-F Guo; M Wang; J Dong; Y Zhang; Z Li; Y-L Shu
Journal:  Arch Virol       Date:  2006-11-02       Impact factor: 2.574

7.  Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs.

Authors:  J S Robertson; C W Naeve; R G Webster; J S Bootman; R Newman; G C Schild
Journal:  Virology       Date:  1985-05       Impact factor: 3.616

8.  Quantitative biochemical rationale for differences in transmissibility of 1918 pandemic influenza A viruses.

Authors:  Aravind Srinivasan; Karthik Viswanathan; Rahul Raman; Aarthi Chandrasekaran; S Raguram; Terrence M Tumpey; V Sasisekharan; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

9.  Structural basis for receptor specificity of influenza B virus hemagglutinin.

Authors:  Qinghua Wang; Xia Tian; Xiaorui Chen; Jianpeng Ma
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-17       Impact factor: 11.205

10.  Crystal structure of unliganded influenza B virus hemagglutinin.

Authors:  Qinghua Wang; Feng Cheng; Mingyang Lu; Xia Tian; Jianpeng Ma
Journal:  J Virol       Date:  2008-01-09       Impact factor: 5.103

View more
  7 in total

1.  Sialoglycovirology of Lectins: Sialyl Glycan Binding of Enveloped and Non-enveloped Viruses.

Authors:  Nongluk Sriwilaijaroen; Yasuo Suzuki
Journal:  Methods Mol Biol       Date:  2020

2.  Determinant of receptor-preference switch in influenza hemagglutinin.

Authors:  Fengyun Ni; Elena Kondrashkina; Qinghua Wang
Journal:  Virology       Date:  2017-10-18       Impact factor: 3.616

3.  Rules of co-occurring mutations characterize the antigenic evolution of human influenza A/H3N2, A/H1N1 and B viruses.

Authors:  Haifen Chen; Xinrui Zhou; Jie Zheng; Chee-Keong Kwoh
Journal:  BMC Med Genomics       Date:  2016-12-05       Impact factor: 3.063

Review 4.  The structural variability of the influenza A hemagglutinin receptor-binding site.

Authors:  Michal Lazniewski; Wayne K Dawson; Teresa Szczepinska; Dariusz Plewczynski
Journal:  Brief Funct Genomics       Date:  2018-11-26       Impact factor: 4.241

Review 5.  Sialic Acid Receptors: The Key to Solving the Enigma of Zoonotic Virus Spillover.

Authors:  Suresh V Kuchipudi; Rahul K Nelli; Abhinay Gontu; Rashmi Satyakumar; Meera Surendran Nair; Murugan Subbiah
Journal:  Viruses       Date:  2021-02-08       Impact factor: 5.048

6.  Elimination of receptor binding by influenza hemagglutinin improves vaccine-induced immunity.

Authors:  Hilary E Hendin; Pierre-Olivier Lavoie; Jason M Gravett; Stéphane Pillet; Pooja Saxena; Nathalie Landry; Marc-André D'Aoust; Brian J Ward
Journal:  NPJ Vaccines       Date:  2022-04-11       Impact factor: 9.399

7.  Functionality of the putative surface glycoproteins of the Wuhan spiny eel influenza virus.

Authors:  Guha Asthagiri Arunkumar; Disha Bhavsar; Tiehai Li; Shirin Strohmeier; Veronika Chromikova; Fatima Amanat; Mehman Bunyatov; Patrick C Wilson; Ali H Ellebedy; Geert-Jan Boons; Viviana Simon; Robert P de Vries; Florian Krammer
Journal:  Nat Commun       Date:  2021-10-25       Impact factor: 17.694

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.